https://www.selleckchem.com/pr....oducts/dt-061-smap.h
s, especially minority, socioeconomically disadvantaged, and uninsured patients, who encounter delays in oncologic care.Airway microparticles (MPs) have been shown previously to inhibit influenza virus by trapping virions on their surface through their surface viral receptor. It was hypothesized that airway MPs may carry most of the epithelial cell surface molecules, including receptors for respiratory viruses, and may be able to inhibit various respiratory viruses. We show here that MPs from human bronchoalveolar lavage (BAL) can i
Like
Comment
Share
